🔎 Trials Near Me

Почетна › Глиобластом › Охајо

Kliničke studije za Глиобластом u državi Охајо

23 studija za Глиобластом traži učesnike na lokacijama u državi Охајо.

Gradovi u državi Охајо

Zvanični tekst studije (na engleskom)

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • Cleveland Clinic Taussig Cancer Center, Cleveland
  • Ohio State University, Columbus
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07326566

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

  • Ohio State University Medical Center, Columbus
Тражи се учесник
Узраст од 18 до 85 · Оба пола · Ажурирано 12. 11. 2026. · NCT06910306

Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

  • The Ohio State University, Columbus
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07195591

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
  • Cleveland Clinic Foundation, Cleveland
  • Ohio State University Comprehensive Cancer Center, Columbus
  • и још 1
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT05432804

Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-Being

  • University Hospitals Cleveland Medical Center, Cleveland
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07628647

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

  • University Hospitals Cleveland Medical Center*, Cleveland
  • Cleveland Clinic, Cleveland
Тражи се учесникФаза 2/3
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT03970447

Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma

  • Ohio State University Hospital, Columbus
Тражи се учесникФаза 1/2
Узраст од 18 до 70 · Оба пола · Ажурирано 23. 10. 2026. · NCT07346144

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

  • Ohio State University Comprehensive Cancer Center, Columbus
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT06860594

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • Ohio State University Comprehensive Cancer Center, Columbus
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 21. 10. 2026. · NCT06810544

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • Cleveland Clinic, Cleveland
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT05303519

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

  • Case Western Reserve University, Cleveland
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 9. 2026. · NCT07452458

hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)

  • University Hospitals Cleveland Medical Center, Cleveland
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 10. 9. 2026. · NCT05052957

Targeted Pediatric High-Grade Glioma Therapy

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
Тражи се учесникОпсервациона студија
12 Months – 39 Years · Оба пола · Ажурирано 8. 9. 2026. · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
Тражи се учесникФаза 2
Узраст од 12 до 39 · Оба пола · Ажурирано 1. 9. 2026. · NCT06161974

Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression

  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 6. 8. 2026. · NCT05565118

A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas

  • Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 6. 8. 2026. · NCT07003542

Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma

  • Ohio State University, Columbus
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 17. 7. 2026. · NCT07225621

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

  • The Ohio State University Comprehensive Cancer Center, Columbus
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 1. 7. 2026. · NCT06805305

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
Тражи се учесникРана фаза 1Здраве особе су добродошле
Узраст од 1 до 21 · Оба пола · Ажурирано 29. 6. 2026. · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  • Cincinnati Children's Hospital Medical Center, Cincinnati
  • Nationwide Children's Hospital, Columbus
Тражи се учесникФаза 2
12 Months – 39 Years · Оба пола · Ажурирано 29. 5. 2026. · NCT05843253

Sacituzumab Govitecan in Recurrent Glioblastoma

  • Cleveland Clinic Taussig Cancer Center, Cleveland
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 30. 3. 2026. · NCT04559230

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Cincinnati
  • Massive Bio SYNERGY-AI site, Columbus
  • Massive Bio SYNERGY-AI site, Mayfield Heights
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

  • The Cleveland Clinic, Cleveland
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 25. 6. 2025. · NCT05879367

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.